The top analyst upgrades, downgrades and initiations seen on Tuesday, include Best Buy, Caterpillar, Nokia, UnitedHealth and Wal-Mart.
Athersys has announced a partnership and license agreement that will focus on the development and commercialization of novel cell therapy treatments.
Source: ThinkstockThe world of biotech investing is always a difficult one. Often a binary event, such as U.S. Food and Drug Administration (FDA) approval or a life-saving capital raise, is the...
The equity markets opened strong this morning, with the Dow trading in narrow band around 140 points up all morning until about 1:30 in the afternoon. Hopeful economic news from Europe started things...
Stem cell stocks (tracked in Tickerspy’s Stem Cell Stock’s Index (*RXSTM) are up over 7% today, led by Athersys Inc (NASDAQ: ATHX). ¬†Athersys Inc. rose as high as 395% this morning...
There are lots of names moving in biotech and related fields today, and below are some of the top movers: Anika Therapeutics Inc. (NASDAQ: ANIK) moving up after reporting solid first quarter earnings...
This is not every bit of news on individual stocks but this is the major news affecting many shares in pre-market activity this Thursday morning: Accenture (ACN) stock up 4% after posting $0.60 EPS...